Amendment #1 to the Evaluation Corporation AgreementEvaluation Corporation Agreement • April 18th, 2011 • Accelr8 Technology Corp • Laboratory analytical instruments
Contract Type FiledApril 18th, 2011 Company IndustryIncorporating the terms and conditions of the Evaluation Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the “Agreement"), made by and between Novartis Vaccines and Diagnostics, Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8”), the Agreement is amended, effective as of November 10, 2010 as set forth herein.
Amendment #1 to the Evaluation Corporation AgreementEvaluation Corporation Agreement • December 14th, 2010 • Accelr8 Technology Corp • Laboratory analytical instruments
Contract Type FiledDecember 14th, 2010 Company IndustryIncorporating the terms and conditions of the Evaluation Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the “Agreement"), made by and between Novartis Vaccines and Diagnostics, Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8”), the Agreement is amended, effective as of November 10, 2010 as set forth herein.